CLAIM #18156 · CVS Health Corp (CVS) · 2022Q4 earnings call · Feb 8, 2023 · due Dec 31, 2026
“These two factors combine to drive clinics to maturity, achieving profitability within the first 3 years and unlocking annual adjusted EBITDA potential of approximately $7 million per clinic using Oak Street’s definition of adjusted EBITDA.”
Shawn Guertin · CFO
How to check this claim
Look at: Mature Oak Street clinic count and total/embedded Oak Street adjusted EBITDA (company-defined), specifically clinics reaching maturity within 3 years of opening at ~$7 million adjusted EBITDA per mature clinic
It came true if: Oak Street clinic count > 300 by end of 2026 AND embedded/mature clinic adjusted EBITDA consistent with ~$7 million per mature clinic (aggregate embedded adjusted EBITDA > $2 billion at that clinic count)
Where: CVS Health company disclosures on Oak Street clinic count and adjusted EBITDA (10-K/investor presentations/earnings calls)
In context
“et that proved to be the most strategically and financially compelling. Oak Street will operate as a payer-agnostic business within CVS Health, focused on improving outcomes and experiences for the Medicare population it serves. CVS Health has a strong and proven track record of helping its payer clients succeed, and we will continue to prioritize that success after this transaction. What we saw when we looked into Oak Street’s portfolio of clinics was a remarkably consistent path to clinic profitability. This trend was true across diverse geographies, populations and payers. As Oak Street drives strong patient experiences and engagement, their patient panels grow. And as Oak Street’s providers engage with those patients, they improve outcomes and increase patient contributions over time. These two factors combine to drive clinics to maturity, achieving profitability within the first 3 years and unlocking annual adjusted EBITDA potential of approximately $7 million per clinic using Oak Street’s definition of adjusted EBITDA. Within the 169 clinics Oak Street has today, we have high visibility into embedded adjusted EBITDA of over $1 billion. We also recognize the tremendous opportunity to scale Oak Street’s clinics to reach more seniors across the nation. At their current rate of expansion, we expect Oak Street to have over 300 clinics by 2026, at which point we project they will have more than $2 billion of embedded Oak Street adjusted EBITDA. Shifting to synergies. We envisioned five main opportunities to realize more than $500 million of value over time: one, accelerating Oak Street patient growth through CVS Health channels; two, improving Oak Street’s economics through integration with our broad portfolio of assets; three, improving the retention of our Aetna MA members through the improved outcomes and”
Verify independently
SEC filings for CVS ↗ · Claim quote is verbatim from the 2022Q4 earnings call.